Research on risk assessment for secondary lymphedema following breast cancer treatment

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 11, 2010, Pages 2715-2717

  Armer, Jane M ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURGERY; CANCER SURVIVOR; DISEASE SEVERITY; DOSIMETRY; EDITORIAL; HUMAN; LYMPHEDEMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHEDEMA; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 78549265550     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0962     Document Type: Editorial

References (17)

1. Langer S, Guenther JM, Haigh PI, Difronzo LA. Lymphatic mapping improves staging and reduces morbidity in women undergoing total mastectomy for breast carcinoma. Am Surg 2004;70:881-5.
2. Schrenk PRR, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000;88:608-14.
3. Ronka RH, Pamilo MS, von Smitten KAJ, Leidenius MHK. Breast lymphedema after breast conserving treatment. Acta Oncologica 2004;43:551-7.
4. Cormier JN, Davidson L, Xing Y, Evans WJ, Armer JM. Lymphedema is common among post-operative cancer survivors. Paper presented at the 2006 Annual Meeting of the American Society of Clinical Oncology; 2006.
5. Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM. Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer 2010.
6. Ries LAG, Melbert D, Krapcho M, et al. SEER cancer statistics review, 1975-2005. National Cancer Institute [retrieved 2010 Sept 7]. Available from: http://seer.cancer.gov/csr/1975-2005/.
7. Wilke L, McCall L, Posther K, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006;13:491-500.
8. National Cancer Institute. Lymphedema PDQ [retrieved 2010 Sept 7]. Available from http://www.cancer.gov/cancertopics/pdq/supportivecare/lymphedema/ HealthProfessional.
9. Armer JM, Stewart BR, Shook RP. 30-month post-breast cancer treatment lymphoedema. J Lymphoedema 2009;4:14-8.
10. Rockson SG. Precipitating factors in lymphedema: myths and realities. Cancer 1998;83:2814-6.
11. Petrek JA, Pressman PI, Smith RA. Lymphedema: current issues in research and management. CA Cancer J Clin 2000;50:292-307.
12. Deutsch M, Flickinger JC. Arm edema after lumpectomy and breast irradiation. Am J Clin Oncol 2003;26:229-31.
13. Kattlove H, Winn RD. Ongoing care of patients after primary treatment for their cancer. CA Cancer J Clin 2003;53:172-96.
14. Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. Q J Med 2005;98:343-8.
15. Rose KE, Taylor HM, Twycross RG. Long-term compliance with treatment in obstructive arm lymphoedema in cancer. Palliat Med 1991;5:52-5.
16. Ward L. Is BIS ready for prime time as the gold standard measure? J Lymphoedema 2009;4:52-6.
17. Armer JM. Secondary lymphedema: imperatives for research to move the field forward. Symposium conducted at the Medicare Evidence Development and Coverage Advisory Committee Meeting. Washington (DC); 2009.